DSCSA Traceability Mechanisms Enable Targeted Pharmaceutical Recalls

The Drug Supply Chain Security Act (DSCSA), initially implemented to ensure compliance within the pharmaceutical industry, is now demonstrating its potential to improve recall processes. Dan Walles, Vice President and General Manager of Traceability and Compliance Solutions at TraceLink, highlighted this development during a recent interview. He stated that while DSCSA’s primary purpose is regulatory compliance, its first significant business application lies in facilitating more precise and efficient product recalls.

Walles explained that the traceability mechanisms established under DSCSA allow companies to conduct targeted recalls rather than broad, sweeping actions. This capability stems from the act’s requirement for enhanced tracking of pharmaceutical products throughout the supply chain. By leveraging these systems, businesses can identify specific batches or shipments affected by quality issues or safety concerns, reducing waste and minimizing disruption to unaffected inventory. The integration of compliance tools with operational processes marks a shift in how companies are utilizing regulatory frameworks beyond their original intent.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

Related posts:

STAT’s D.C. Diagnosis Newsletter: Bi-Weekly Updates on Health Policy in Washington D.C. Modified mRNA Vaccines Incorporating IL-12 Show Enhanced T Cell Activation in Immune Response Study Eastern Michigan University Student Develops KISS App to Address Rising STI Rates Monkeypox Outbreak in Central African Republic 2024 Shows Expanded Demographic and Geographic Impact

Author

GOAI